This contract expires in 64 days (Aug 9, 2026).

Browse related active opportunities

FIRM FIXED PRICE

MCKESSON CORPORATION - MCKESSON: CONTROLLED MEDICATION DOS: OCTOBER 1, 2025 THRU AUGUST 9, 2026 FUNDING THROUGH JANUARY 31, 2026

PIID: 15B10626F00000035
Signed Date: Nov 26, 2025Effective Date: Oct 1, 2025End Date: Closes in 64 days
Award $
$58K
Vendor
MCKESSON CORPORATION
NAICS
325412
Signed Date
Nov 26, 2025

Key Details

Dollars Obligated
$58,000
Base & All Options
$58,000
Awarding Agency
Department of Justice
Awarding Sub-Agency
Federal Prison System / Bureau of Prisons
Product Service Code
6505 - DRUGS AND BIOLOGICALS
Extent Competed
FULL AND OPEN COMPETITION
Place of Performance
IRVING, TX, 750392402, CD-TX-33

Description

MCKESSON: CONTROLLED MEDICATION DOS: OCTOBER 1, 2025 THRU AUGUST 9, 2026 FUNDING THROUGH JANUARY 31, 2026

Context & Analysis

On Nov 26, 2025, Department of Justice obligated $58,000 to MCKESSON CORPORATION for mckesson: controlled medication dos: october 1, 2025 thru august 9, 2026 funding through january 31, 2026. The award is classified under NAICS 325412 — PHARMACEUTICAL PREPARATION MANUFACTURING and issued as a firm fixed price contract. Competition extent: full and open competition. Performance is located in IRVING, TX. The contract is scheduled through Aug 9, 2026 — approximately 2 months remaining. This award is one of several similar procurements from Department of Justice under NAICS 325412 — related awards are listed below.

Contractor Information

UEI: S1RUKWWRYFL6
CAGE Code: 1MKG3
Location: IRVING, TX
View Full Record on USASpending.gov

Stay Updated

Get notified about new opportunities matching your interests.

Related